<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title40.html">
                                    Title 40
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/40CFR79.html">Part 79
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 79.60  Good laboratory practices (GLP) standards for inhalation exposure health effects testing.
                            </h3>
                            <p class="depth0"><em>(a)</em> General Provisions--</p><p class="depth0"><em>(1)</em> Scope. </p><p class="depth0"><em>(i)</em> This section prescribes good  laboratory practices (GLPs) for conducting inhalation exposure studies  relating to motor vehicle emissions health effects testing under this  part. These directions are intended to ensure the quality and integrity  of health effects data submitted pursuant to registration regulations  issued under sections 211(b) or 211(e) of the Clean Air Act (CAA) (42  U.S.C. 7545).</p><p class="depth0"><em>(ii)</em> This section applies to any study described by paragraph  (a)(1)(i) of this section which any person conducts, initiates, or  supports on or after May 27, 1994.</p><p class="depth0"><em>(iii)</em> It is EPA's policy that all health effects data developed  under sections 211(b) and (e) of CAA be in accordance with provisions of  this section. If data are not developed in accordance with the  provisions of this section, EPA may consider such data insufficient to  evaluate the health effects of a motor vehicle's fuel or fuel additive  emissions, unless the submitter provides additional information  demonstrating that the data are reliable and adequate and EPA determines  that the data are sufficient.</p><p class="depth0"><em>(2)</em> Definitions. As used in this section, the following terms shall  have the meanings specified:</p><p class="depth0">Batch means a specific quantity or lot of a test fuel, additive/base  fuel mixture, or reference substance that has been characterized  according to Sec. 79.60(f)(1)(i).</p><p class="depth0">CAA means the Clean Air Act.</p><p class="depth0">Carrier means any material which is combined with engine/motor  vehicle emissions or a reference substance for administration to a test  system. ``Carrier'' includes, but is not limited to, clean, filtered  air, water, feed, and nutrient media.</p><p class="depth0">Control atmosphere means clean, filtered air which is administered  to the test system in the course of a study for the purpose of  establishing a basis for comparison with the test atmosphere for  chemical or biological measurements.</p><p class="depth0">Experimental start date means the first date the test atmosphere is  applied to the test system.</p><p class="depth0">Experimental termination date means the last date on which data are  collected directly from the study.</p><p class="depth0">Person includes an individual, partnership, corporation,  association, scientific or academic establishment, government agency, or  organizational unit thereof, and any other legal entity.</p><p class="depth0">Quality assurance unit means any person or organizational element,  except the study director, designated by testing facility management to  perform the duties relating to quality assurance of the studies.</p><p class="depth0">Raw data means any laboratory worksheets, records, memoranda, notes,  or exact copies thereof, that are the result of original observations  and activities of a study and are necessary for the reconstruction and  evaluation of the report of that study. In the event that exact  transcripts of raw data have been prepared (e.g., tapes which have been  transcribed verbatim, dated, and verified accurate by signature), the  exact copy or exact transcript may be substituted for the original  source as raw data. ``Raw data'' may include photographs, videotape,  microfilm or microfiche copies, computer printouts, magnetic media,  including dictated observations, and recorded data from automated  instruments.</p><p class="depth0">Reference substance means any chemical substance or mixture,  analytical standard, or material other than engine/motor vehicle  emissions and/or its carrier, that is administered to or used in  analyzing the test system in the course of a study. A ``reference  substance'' is used to establish a basis for comparison with the test  atmosphere for known chemical or biological measurements, i.e., positive  or negative control substance.</p><p class="depth0">Specimen means any material derived from a test system for  examination or analysis.</p><p class="depth0">Sponsor means person who initiates and supports, by provision of  financial or other resources, a study or a person who submits a study to  EPA in response to the CAA Section 211(b) or 211(e) Fuels and Fuel  Additives Registration Rule or a testing facility, if it both initiates  and actually conducts the study.</p><p class="depth0">Study means any experiment, at one or more test sites, in which a  test system is exposed to a test atmosphere under laboratory conditions  to determine or help predict the health effects of that exposure in  humans, other living organisms, or media.</p><p class="depth0">Study completion date means the date the final report is signed by  the study director.</p><p class="depth0">Study director means the individual responsible for the overall  conduct of a study.</p><p class="depth0">Study initiation date means the date the protocol is signed by the  study director.</p><p class="depth0">Test substance means a vapor and/or aerosol mixture composed of  engine/motor vehicle emissions and clean, filtered air which is  administered directly, or indirectly, by the inhalation route to a test  system in a study which develops data to meet the registration  requirements of CAA section 211(b) or (e).</p><p class="depth0">Test system means any animal, microorganism, chemical or physical  matrix, to which the test, control, or reference substance is  administered or added for study. This definition also includes  appropriate groups or components of the system not treated with the  test, control, or reference substance.</p><p class="depth0">Testing facility means a person who actually conducts a study, i.e.,  actually uses the test substance in a test system. ``Testing facility''  encompasses only those operational units that are being or have been  used to conduct studies.</p><p class="depth0">TSCA means the Toxic Substances Control Act (15 U.S.C. 2601 et  seq.).</p><p class="depth0"><em>(3)</em> Applicability to studies performed under grants and contracts.  When a   sponsor or other person utilizes the services of a consulting  laboratory, contractor, or grantee to perform all or a part of a study  to which this section applies, it shall notify the consulting  laboratory, contractor, or grantee that the service is, or is part of, a  study that must be conducted in compliance with the provisions of this  section.</p><p class="depth0"><em>(4)</em> Statement of compliance or non-compliance. Any person who  submits to EPA a test in compliance with registration regulations issued  under CAA section 211(b) or section 211(e) shall include in the  submission a true and correct statement, signed by the sponsor and the  study director, of one of the following types:</p><p class="depth0"><em>(i)</em> A statement that the study was conducted in accordance with this  section; or</p><p class="depth0"><em>(ii)</em> A statement describing in detail all differences between the  practices used in the study and those required by this section; or</p><p class="depth0"><em>(iii)</em> A statement that the person was not a sponsor of the study,  did not conduct the study, and does not know whether the study was  conducted in accordance with this section.</p><p class="depth0"><em>(5)</em> Inspection of a testing facility. </p><p class="depth0"><em>(i)</em> A testing facility shall  permit an authorized employee or duly designated representative of EPA,  at reasonable times and in a reasonable manner, to inspect the facility  and to inspect (and in the case of records also to copy) all records and  specimens required to be maintained regarding studies to which this  section applies. The records inspection and copying requirements shall  not apply to quality assurance unit records of findings and problems, or  to actions recommended and taken, except the EPA may seek production of  these records in litigation or formal adjudicatory hearings.</p><p class="depth0"><em>(ii)</em> EPA will not consider reliable for purposes of showing that a  test substance does or does not present a risk of injury to health or  the environment any data developed by a testing facility or sponsor that  refuses to permit inspection in accordance with this section. The  determination that a study will not be considered reliable does not,  however, relieve the sponsor of a required test of any obligation under  any applicable statute or regulation to submit the results of the study  to EPA.</p><p class="depth0"><em>(6)</em> Effects of non-compliance. </p><p class="depth0"><em>(i)</em> Pursuant to sections 114, 208,  and 211(d) of the CAA, it shall be a violation of this section and a  violation of this rule (40 CFR part 79, subpart F) if:</p><p class="depth0"><em>(A)</em> The test is not being or was not conducted in accordance with  any requirement of this part; or</p><p class="depth0"><em>(B)</em> Data or information submitted to EPA under part 79, including  the statement required by Sec. 79.60(a)(4), include information or data  that are false or misleading, contain significant omissions, or  otherwise do not fulfill the requirements of this part; or</p><p class="depth0"><em>(C)</em> Entry in accordance with Sec. 79.60(a)(5) for the purpose of  auditing test data is denied.</p><p class="depth0"><em>(ii)</em> EPA, at its discretion, may not consider reliable for purposes  of showing that a chemical substance or mixture does not present a risk  of injury to health any study which was not conducted in accordance with  this part. EPA, at its discretion, may rely upon such studies for  purposes of showing adverse effects. The determination that a study will  not be considered reliable does not, however, relieve the sponsor of a  required test of the obligation under any applicable statute or  regulation to submit the results of the study to EPA.</p><p class="depth0"><em>(iii)</em> If data submitted in compliance with registration regulations  issued under CAA section 211(b) or section 211(e) are not developed in  accordance with this section, EPA may determine that the sponsor has not  fulfilled its obligations under 40 CFR part 79 and may require the  sponsor to develop data in accordance with the requirements of this  section in order to satisfy such obligations.</p><p class="depth0"><em>(b)</em> Organization and Personnel--</p><p class="depth0"><em>(1)</em> Personnel. </p><p class="depth0"><em>(i)</em> Each individual  engaged in the conduct of or responsible for the supervision of a study  shall have education, training, and experience, or combination thereof,  to enable that individual to perform the assigned functions.</p><p class="depth0"><em>(ii)</em> Each testing facility shall maintain a current summary of  training and experience and job description for each individual engaged  in or supervising the conduct of a study.</p><p class="depth0"><em>(iii)</em> There shall be a sufficient number of personnel for the timely  and proper conduct of the study according to the protocol.</p><p class="depth0"><em>(iv)</em> Personnel shall take necessary personal sanitation and health  precautions designed to avoid contamination of test fuel and additive/ base fuel mixtures, test and reference substances, and test systems.</p><p class="depth0"><em>(v)</em> Personnel engaged in a study shall wear clothing appropriate for  the duties they perform. Such clothing shall be changed as often as  necessary to prevent microbiological, radiological, or chemical  contamination of test systems and test, control, and reference  substances.</p><p class="depth0"><em>(vi)</em> Any individual found at any time to have an illness that may  adversely affect the quality and integrity of the study shall be  excluded from direct contact with test systems, fuel and fuel/additive  mixtures, test and reference substances and any other operation or  function that may adversely affect the study until the condition is  corrected. All personnel shall be instructed to report to their  immediate supervisors any health or medical conditions that may  reasonably be considered to have an adverse effect on a study.</p><p class="depth0"><em>(2)</em> Testing facility management. For each study, testing facility  management shall:</p><p class="depth0"><em>(i)</em> Designate a study director as described in Sec. 79.60(b)(3)  before the study is initiated.</p><p class="depth0"><em>(ii)</em> Replace the study director promptly if it becomes necessary to  do so during the conduct of a study.</p><p class="depth0"><em>(iii)</em> Assure that there is a quality assurance unit as described in  Sec. 79.60(b)(4).</p><p class="depth0"><em>(iv)</em> Assure that test fuels and fuel/additive mixtures and test and  reference substances have been identified as to content, strength,  purity, stability, and uniformity, as applicable.</p><p class="depth0"><em>(v)</em> Assure that personnel, resources, facilities, equipment,  materials and methodologies are available as scheduled.</p><p class="depth0"><em>(vi)</em> Assure that personnel clearly understand the functions they are  to perform.</p><p class="depth0"><em>(vii)</em> Assure that any deviations from these regulations reported by  the quality assurance unit are communicated to the study director and  corrective actions are taken and documented.</p><p class="depth0"><em>(3)</em> Study director. For each study, a scientist or other  professional person with a doctorate degree or equivalent in toxicology  or other appropriate discipline shall be identified as the study  director. The study director has overall responsibility for the  technical conduct of the study, as well as for the interpretation,  analysis, documentation, and reporting of results, and represents the  single point of study control. The study director shall assure that:</p><p class="depth0"><em>(i)</em> and is followed;</p><p class="depth0"><em>(ii)</em> All experimental data, including observations of unanticipated  responses of the test system are accurately recorded and verified;</p><p class="depth0"><em>(iii)</em> Unforeseen circumstances that may affect the quality and  integrity of the study are noted when they occur, and corrective action  is taken and documented;</p><p class="depth0"><em>(iv)</em> Test systems are as specified in the protocol;</p><p class="depth0"><em>(v)</em> All applicable good laboratory practice regulations are  followed; and</p><p class="depth0"><em>(vi)</em> All raw data, documentation, protocols, specimens, and final  reports are archived properly during or at the close of the study.</p><p class="depth0"><em>(4)</em> Quality assurance unit. A testing facility shall have a quality  assurance unit which shall be responsible for monitoring each study to  assure management that the facilities, equipment, personnel, methods,  practices, records, and controls are in conformance with the regulations  in this section. For any given study, the quality assurance unit shall  be entirely separate from and independent of the personnel engaged in  the direction and conduct of that study. The quality assurance unit  shall conduct inspections and maintain records appropriate to the study.</p><p class="depth0"><em>(i)</em> Quality assurance unit duties. </p><p class="depth0"><em>(A)</em> Maintain a copy of a master  schedule sheet of all studies conducted at the testing facility indexed  by test substance and containing the test system, nature of study, date  study was initiated, current status of each study, identity of the  sponsor, and name of the study director.</p><p class="depth0"><em>(B)</em> Maintain copies of all protocols pertaining to all studies for  which the unit is responsible.</p><p class="depth0"><em>(C)</em> Inspect each study at intervals adequate to ensure the integrity  of the study and maintain written and properly signed records of each  periodic inspection showing the date of the inspection, the study  inspected, the phase or segment of the study inspected, the person  performing the inspection, findings and problems, action recommended and  taken to resolve existing problems, and any scheduled date for re- inspection. Any problems which are likely to affect study integrity  found during the course of an inspection shall be brought to the  attention of the study director and management immediately.</p><p class="depth0"><em>(D)</em> Periodically submit to management and the study director written  status reports on each study, noting any problems and the corrective  actions taken.</p><p class="depth0"><em>(E)</em> Determine that no deviations from approved protocols or standard  operating procedures were made without proper authorization and  documentation.</p><p class="depth0"><em>(F)</em> Review the final study report to assure that such report  accurately describes the methods and standard operating procedures, and  that the reported results accurately reflect the raw data of the study.</p><p class="depth0"><em>(G)</em> Prepare and sign a statement to be included with the final study  report which shall specify the dates inspections were made and findings  reported to management and to the study director.</p><p class="depth0"><em>(ii)</em> The responsibilities and procedures applicable to the quality  assurance unit, the records maintained by the quality assurance unit,  and the method of indexing such records shall be in writing and shall be  maintained. These items including inspection dates, the study inspected,  the phase or segment of the study inspected, and the name of the  individual performing the inspection shall be made available for  inspection to authorized employees or duly designated representatives of  EPA.</p><p class="depth0"><em>(iii)</em> An authorized employee or a duly designated representative of  EPA shall have access to the written procedures established for the  inspection and may request test facility management to certify that  inspections are being implemented, performed, documented, and followed  up in accordance with this paragraph.</p><p class="depth0"><em>(c)</em> Facilities--</p><p class="depth0"><em>(1)</em> General. Each testing facility shall be of  suitable size and construction to facilitate the proper conduct of  studies. Testing facilities which are not completely located within an  indoor controlled environment shall be of suitable location/proximity to  facilitate the proper conduct of studies. Testing facilities shall be  designed so that there is a degree of separation that will prevent any  function or activity from having an adverse effect on the study.</p><p class="depth0"><em>(2)</em> Test system care facilities. </p><p class="depth0"><em>(i)</em> A testing facility shall have a  sufficient number of animal rooms or other test system areas, as needed,  to ensure proper separation of species or test systems, quarantine or  isolation of animals or other test systems, and routine or specialized  housing of animals or other test systems.</p><p class="depth0"><em>(ii)</em> A testing facility shall have a number of animal rooms or other  test system areas separate from those described in paragraph (a) of this  section to ensure isolation of studies being done with test systems or  test, control, and reference substances known to be biohazardous,  including volatile atmospheres and aerosols, radioactive materials, and  infectious agents. The animal handling facility must operate under the  supervision of a veterinarian.</p><p class="depth0"><em>(iii)</em> Separate areas shall be provided, as appropriate, for the  diagnosis, treatment, and control of laboratory test system diseases.  These areas shall provide effective isolation for the housing of test  systems either known or suspected of being diseased, or of being  carriers of disease, from other test systems.</p><p class="depth0"><em>(iv)</em> Facilities shall have proper provisions for collection and  disposal of contaminated air, water, or other spent materials. When  animals are housed, facilities shall exist for the collection and  disposal of all animal waste and refuse or for safe sanitary storage of  waste before removal from the testing facility. Disposal facilities  shall be so provided and operated as to minimize   vermin infestation, odors, disease hazards, and environmental  contamination.</p><p class="depth0"><em>(v)</em> Facilities shall have provisions to regulate environmental  conditions (e.g., temperature, humidity, day length, etc.) as specified  in the protocol.</p><p class="depth0"><em>(3)</em> Test system supply/operation areas. </p><p class="depth0"><em>(i)</em> There shall be storage  areas, as needed, for feed, bedding, supplies, and equipment. Storage  areas for feed and bedding shall be separated from areas where the test  systems are located and shall be protected against infestation or  contamination. Perishable supplies shall be preserved by appropriate  means.</p><p class="depth0"><em>(ii)</em> Separate laboratory space and other space shall be provided, as  needed, for the performance of the routine and specialized procedures  required by studies.</p><p class="depth0"><em>(4)</em> Facilities for handling test fuels and fuel/additive mixtures  and reference substances. </p><p class="depth0"><em>(i)</em> As necessary to prevent contamination or  mixups, there shall be separate areas for:</p><p class="depth0"><em>(A)</em> Receipt and storage of the test fuels and fuel/additive mixtures  and reference substances;</p><p class="depth0"><em>(B)</em> Mixing of the test fuels, fuel/additive mixtures, and reference  substances with a carrier, i.e., liquid hydrocarbon; and</p><p class="depth0"><em>(C)</em> Storage of the test fuels, fuel/additive mixtures, and reference  substance/carrier mixtures.</p><p class="depth0"><em>(ii)</em> Storage areas for test fuels and fuel/additive mixtures and  reference substances and for reference mixtures shall be separate from  areas housing the test systems and shall be adequate to preserve the  identity, strength, purity, and stability of the substances and  mixtures.</p><p class="depth0"><em>(5)</em> Specimen and data storage facilities. Space shall be secured for  archives for the storage and retrieval of all raw data and specimens  from completed studies.</p><p class="depth0"><em>(d)</em> Equipment--</p><p class="depth0"><em>(1)</em> Equipment design. Equipment used in the  generation, measurement, or assessment of data and equipment used for  facility environmental control shall be of appropriate design and  adequate capacity to function according to the protocol and shall be  suitably located for operation, inspection, cleaning, and maintenance.</p><p class="depth0"><em>(2)</em> Maintenance and calibration of equipment. </p><p class="depth0"><em>(i)</em> Equipment shall be  adequately inspected, cleaned, and maintained. Equipment used for the  generation, measurement, or assessment of data shall be adequately  tested, calibrated, and/or standardized.</p><p class="depth0"><em>(ii)(K)</em> shall set forth in sufficient detail the  methods, materials, and schedules to be used in the routine inspection,  cleaning, maintenance, testing, calibration, and/or standardization of  equipment, and shall specify, when appropriate, remedial action to be  taken in the event of failure or malfunction of equipment. The written  standard operating procedures shall designate the person responsible for  the performance of each operation.</p><p class="depth0"><em>(iii)</em> Written records shall be maintained of all inspection,  maintenance, testing, calibrating, and/or standardizing operations.  These records, containing the date of the operation, shall describe  whether the maintenance operations were routine and followed the written  standard operating procedures. Written records shall be kept of non- routine repairs performed on equipment as a result of failure and  malfunction. Such records shall document the nature of the defect, how  and when the defect was discovered, and any remedial action taken in  response to the defect.</p><p class="depth0"><em>(e)</em> Testing Facilities Operation--</p><p class="depth0"><em>(1)</em> Standard operating procedures.  </p><p class="depth0"><em>(i)</em> A testing facility shall have standard operating procedures in  writing, setting forth study methods that management is satisfied are  adequate to insure the quality and integrity of the data generated in  the course of a study. All deviations in a study from standard operating  procedures shall be authorized by the study director and shall be  documented in the raw data. Significant changes in established standard  operating procedures shall be properly authorized in writing by  management.</p><p class="depth0"><em>(ii)</em> Standard operating procedures shall be established for, but not  limited to, the following:</p><p class="depth0"><em>(A)</em> Test system room preparation;</p><p class="depth0"><em>(B)</em> Test system care;</p><p class="depth0"><em>(C)</em> Receipt, identification, storage, handling, mixing, and method  of sampling of test fuels and fuel/additive mixtures and reference  substances;</p><p class="depth0"><em>(D)</em> Test system observations;</p><p class="depth0"><em>(E)</em> Laboratory or other tests;</p><p class="depth0"><em>(F)</em> Handling of test animals found moribund or dead during study;</p><p class="depth0"><em>(G)</em> Necropsy or postmortem examination of test animals;</p><p class="depth0"><em>(H)</em> Collection and identification of specimens;</p><p class="depth0"><em>(I)</em> Histopathology</p><p class="depth0"><em>(J)</em> Data handling, storage and retrieval.</p><p class="depth0"><em>(K)</em> Maintenance and calibration of equipment.</p><p class="depth0"><em>(L)</em> Transfer, proper placement, and identification of test systems.</p><p class="depth0"><em>(iii)</em> Each laboratory or other study area shall have immediately  available manuals and standard operating procedures relative to the  laboratory procedures being performed. Published literature may be used  as a supplement to standard operating procedures.</p><p class="depth0"><em>(iv)</em> A historical file of standard operating procedures, and all  revisions thereof, including the dates of such revisions, shall be  maintained.</p><p class="depth0"><em>(2)</em> Reagents and solutions. All reagents and solutions in the  laboratory areas shall be labeled to indicate identity, titer or  concentration, storage requirements, and expiration date. Deteriorated  or outdated reagents and solutions shall not be used.</p><p class="depth0"><em>(3)</em> Animal and other test system care. </p><p class="depth0"><em>(i)</em> There shall be standard  operating procedures for the housing, feeding, handling, and care of  animals and other test systems.</p><p class="depth0"><em>(ii)</em> All newly received test systems from outside sources shall be  isolated and their health status or appropriateness for the study shall  be evaluated. This evaluation shall be in accordance with acceptable  veterinary medical practice or scientific methods.</p><p class="depth0"><em>(iii)</em> At the initiation of a study, test systems shall be free of  any disease or condition that might interfere with the purpose or  conduct of the study. If during the course of the study, the test  systems contract such a disease or condition, the diseased test systems  shall be isolated, if necessary. These test systems may be treated for  disease or signs of disease provided that such treatment does not  interfere with the study. The diagnosis, authorization of treatment,  description of treatment, and each date of treatment shall be documented  and shall be retained.</p><p class="depth0"><em>(iv)</em> When laboratory procedures require test animals to be  manipulated and observed over an extended period of time or when studies  require test animals to be removed from and returned to their housing  units for any reason (e.g., cage cleaning, treatment, etc.), these test  systems shall receive appropriate identification (e.g., tattoo, color  code, etc.). Test system identification shall conform with current  laboratory animal handling practice. All information needed to  specifically identify each test system within the test system-housing  unit shall appear on the outside of that unit. Suckling animals are  excluded from the requirement of individual identification unless  otherwise specified in the protocol.</p><p class="depth0"><em>(v)(A)</em> of this section,  test animals of different species shall be housed in separate rooms when  necessary. Test animals of the same species, but used in different  studies, shall not ordinarily be housed in the same room when  inadvertent exposure to the test or reference substances or test system  mixup could affect the outcome of either study. If such mixed housing is  necessary, adequate differentiation by space and identification shall be  made.</p><p class="depth0"><em>(A)</em> Test systems that may be used in multispecies tests need not be  housed in separate rooms, provided that they are adequately segregated  to avoid mixup and cross-contamination.</p><p class="depth0"><em>(B)</em> [Reserved]</p><p class="depth0"><em>(vi)</em> Cages, racks, pens, enclosures, and other holding, rearing, and  breeding areas, and accessory equipment, shall be cleaned and sanitized  at appropriate intervals.</p><p class="depth0"><em>(vii)</em> Feed and water used for the test animals shall be analyzed  periodically to ensure that contaminants known to be capable of  interfering with the study and reasonably expected to be present in such  feed or water are not present at greater than trace levels.  Documentation of such analyses shall be maintained as raw data.</p><p class="depth0"><em>(viii)</em> Bedding used in animal cages or pens shall not interfere with  the purpose or conduct of the study and shall be changed as often as  necessary to keep the animals dry and clean.</p><p class="depth0"><em>(ix)</em> If any pest control materials are used, the use shall be  documented. Cleaning and pest control materials that interfere with the  study shall not be used.</p><p class="depth0"><em>(x)</em> All test systems shall be acclimatized to the environmental  conditions of the test, prior to their use in a study.</p><p class="depth0"><em>(f)</em> Test fuels, additive/base fuel mixtures, and reference  substances--</p><p class="depth0"><em>(1)</em> Test fuel, fuel/additive mixture, and reference  substance identity. </p><p class="depth0"><em>(i)</em> The product brand name/service mark, strength,  purity, content, or other characteristics which appropriately define the  test fuel, fuel/additive mixture, or reference substance shall be  reported for each batch and shall be documented before its use in a  study. Methods of synthesis, fabrication, or derivation, as appropriate,  of the test fuel, fuel/additive mixture, or reference substance shall be  documented by the sponsor or the testing facility, and such location of  documentation shall be specified.</p><p class="depth0"><em>(ii)</em> The stability of test fuel, fuel/additive mixture, and  reference substances under storage conditions at the test site shall be  known for all studies.</p><p class="depth0"><em>(2)</em> Test fuel, additive/base fuel mixture, and reference substance  handling. Procedures shall be established for a system for the handling  of the test fuel, fuel/additive mixture, and reference substance(s) to  ensure that:</p><p class="depth0"><em>(i)</em> There is proper storage.</p><p class="depth0"><em>(ii)</em> Distribution is made in a manner designed to preclude the  possibility of contamination, deterioration, or damage.</p><p class="depth0"><em>(iii)</em> Proper identification is maintained throughout the  distribution process.</p><p class="depth0"><em>(iv)</em> The receipt and distribution of each batch is documented. Such  documentation shall include the date and quantity of each batch  distributed or returned.</p><p class="depth0"><em>(3)</em> Mixtures of test emissions or reference solutions with carriers.</p><p class="depth0"><em>(i)</em> For test emissions or each reference substance mixed with a  carrier, tests by appropriate analytical methods shall be conducted:</p><p class="depth0"><em>(A)</em> To determine the uniformity of the test substance and to  determine, periodically, the concentration of the test emissions or  reference substance in the mixture;</p><p class="depth0"><em>(B)</em> When relevant to the conduct of the experiment, to determine the  solubility of each reference substance in the carrier mixture before the  experimental start date; and</p><p class="depth0"><em>(C)</em> To determine the stability of test emissions or a reference  solution in the test substance before the experimental start date or  concomitantly according to written standard operating procedures, which  provide for periodic analysis of each batch.</p><p class="depth0"><em>(ii)</em> Where any of the components of the reference substance/carrier  mixture has an expiration date, that date shall be clearly shown on the  container. If more than one component has an expiration date, the  earliest date shall be shown.</p><p class="depth0"><em>(iii)</em> If a chemical or physical agent is used to facilitate the  mixing of a test substance with a carrier, assurance shall be provided  that the agent does not interfere with the integrity of the test.</p><p class="depth0"><em>(g)</em> Protocol for and conduct of a study--</p><p class="depth0"><em>(1)</em> Protocol. </p><p class="depth0"><em>(i)</em> Each  study shall have a written protocol that clearly indicates the  objectives and all methods for the conduct of the study. The protocol  shall contain but shall not be limited to the following information:</p><p class="depth0"><em>(A)</em> A descriptive title and statement of the purpose of the study.</p><p class="depth0"><em>(B)</em> Identification of the test fuel, fuel/additive mixture, and  reference substance by name, chemical abstracts service (CAS) number or  code number, as applicable.</p><p class="depth0"><em>(C)</em> The name and address of the sponsor and the name and address of  the testing facility at which the study is being conducted.</p><p class="depth0"><em>(D)</em> The proposed experimental start and termination dates.</p><p class="depth0"><em>(E)</em> Justification for selection of the test system, as necessary.</p><p class="depth0"><em>(F)</em> Where applicable, the number, body weight, sex, source of  supply, species, strain, substrain, and age of the test system.</p><p class="depth0"><em>(G)</em> The procedure for identification of the test system.</p><p class="depth0"><em>(H)</em> A description of the experimental design, including methods for  the control of bias.</p><p class="depth0"><em>(I)</em> Where applicable, a description and/or identification of the  diet used in the study. The description shall include specifications for  acceptable levels of contaminants that are reasonably expected to be  present in the dietary materials and are known to be capable of  interfering with the purpose or conduct of the study if present at  levels greater than established by the specifications.</p><p class="depth0"><em>(J)</em> Each concentration level, expressed in milligrams per cubic  meter of air or other appropriate units, of the test or reference  substance to be administered and the frequency of administration.</p><p class="depth0"><em>(K)</em> The type and frequency of tests, analyses, and measurements to  be made.</p><p class="depth0"><em>(L)</em> The records to be maintained.</p><p class="depth0"><em>(M)</em> The date of approval of the protocol by the sponsor and the  dated signature of the study director.</p><p class="depth0"><em>(N)</em> A statement of the proposed statistical method.</p><p class="depth0"><em>(ii)</em> All changes in or revisions of an approved protocol and the  reasons therefor shall be documented, signed by the study director,  dated, and maintained with the protocol.</p><p class="depth0"><em>(2)</em> Conduct of a study. </p><p class="depth0"><em>(i)</em> The study shall be conducted in  accordance with the protocol.</p><p class="depth0"><em>(ii)</em> The test systems shall be monitored in conformity with the  protocol.</p><p class="depth0"><em>(iii)</em> Specimens shall be identified by test system, study, nature,  and date of collection. This information shall be located on the  specimen container or shall accompany the specimen in a manner that  precludes error in the recording and storage of data.</p><p class="depth0"><em>(iv)</em> In animal studies where histopathology is required, records of  gross findings for a specimen from postmortem observations shall be  available to a pathologist when examining that specimen  histopathologically.</p><p class="depth0"><em>(v)</em> All data generated during the conduct of a study, except those  that are generated by automated data collection systems, shall be  recorded directly, promptly, and legibly in ink. All data entries shall  be dated on the day of entry and signed or initialed by the person  entering the data. Any change in entries shall be made so as not to  obscure the original entry, shall indicate the reason for such change,  and shall be dated and signed or identified at the time of the change.  In automated data collection systems, the individual responsible for  direct data input shall be identified at the time of data input. Any  change in automated data entries shall be made so as not to obscure the  original entry, shall indicate the reason for change, shall be dated,  and the responsible individual shall be identified.</p><p class="depth0"><em>(h)</em> Records and Reports--</p><p class="depth0"><em>(1)</em> Reporting of study results. </p><p class="depth0"><em>(i)</em> A final  report shall be prepared for each study and shall include, but not  necessarily be limited to, the following:</p><p class="depth0"><em>(A)</em> Name and address of the facility performing the study and the  dates on which the study was initiated and was completed, terminated, or  discontinued.</p><p class="depth0"><em>(B)</em> Objectives and procedures stated in the approved protocol,  including any changes in the original protocol.</p><p class="depth0"><em>(C)</em> Statistical methods employed for analyzing the data.</p><p class="depth0"><em>(D)</em> The test fuel, additive/base fuel mixture, and test and  reference substances identified by name, chemical abstracts service  (CAS) number or code number, strength, purity, content, or other  appropriate characteristics.</p><p class="depth0"><em>(E)</em> Stability, and when relevant to the conduct of the study, the  solubility of the test emissions and reference substances under the  conditions of administration.</p><p class="depth0"><em>(F)</em> A description of the methods used.</p><p class="depth0"><em>(G)</em> A description of the test system used. Where applicable, the  final report shall include the number of animals or other test organisms  used, sex, body weight range, source of supply, species, strain and  substrain, age, and procedure used for identification.</p><p class="depth0"><em>(H)</em> A description of the concentration regimen as daily exposure  period, i.e., number of hours, and exposure duration, i.e., number of  days.</p><p class="depth0"><em>(I)</em> A description of all circumstances that may have affected the  quality or integrity of the data.</p><p class="depth0"><em>(J)</em> The name of the study director, the names of other scientists or  professionals and the names of all supervisory personnel, involved in  the study.</p><p class="depth0"><em>(K)</em> A description of the transformations, calculations, or  operations performed on the data, a summary and analysis of the data,  and a statement of the conclusions drawn from the analysis.</p><p class="depth0"><em>(L)</em> The signed and dated reports of each of the individual  scientists or other professionals involved in the study, including each  person who, at the request or direction of the testing facility or  sponsor, conducted an analysis or evaluation of data or specimens from  the study after data generation was completed.</p><p class="depth0"><em>(M)</em> The locations where all specimens, raw data, and the final  report are to be kept or stored.</p><p class="depth0"><em>(N)</em> The statement, prepared and signed by the quality assurance  unit, as described in Sec. 79.60(b)(4)(i)(G).</p><p class="depth0"><em>(ii)</em> The final report shall be signed and dated by the study  director.</p><p class="depth0"><em>(iii)</em> Corrections or additions to a final report shall be in the  form of an amendment by the study director. The amendment shall clearly  identify that part of the final report that is being added to or  corrected and the reasons for the correction or addition, and shall be  signed and dated by the person responsible. Modification of a final  report to comply with the submission requirements of EPA does not  constitute a correction, addition, or amendment to a final report.</p><p class="depth0"><em>(iv)</em> A copy of the final report and of any amendment to it shall be  maintained by the sponsor and the test facility.</p><p class="depth0"><em>(2)</em> Storage and retrieval of records and data. </p><p class="depth0"><em>(i)</em> All raw data,  documentation, records, protocols, specimens, and final reports  generated as a result of a study shall be retained. Specimens obtained  from mutagenicity tests, wet specimens of blood, urine, feces, and  biological fluids, do not need to be retained after quality assurance  verification. Correspondence and other documents relating to  interpretation and evaluation of data, other than those documents  contained in the final report, also shall be retained.</p><p class="depth0"><em>(ii)</em> All raw data, documentation, protocols, specimens, and interim  and final reports shall be archived for orderly storage and expedient  retrieval. Conditions of storage shall minimize deterioration of the  documents or specimens in accordance with the requirements for the time  period of their retention and the nature of the documents of specimens.  A testing facility may contract with commercial archives to provide a  repository for all material to be retained. Raw data and specimens may  be retained elsewhere provided that the archives have specific reference  to those other locations.</p><p class="depth0"><em>(iii)</em> An individual shall be identified as responsible for the  archiving of records.</p><p class="depth0"><em>(iv)</em> Access to archived material shall require authorization and  documentation.</p><p class="depth0"><em>(v)</em> Archived material shall be indexed to permit expedient  retrieval.</p><p class="depth0"><em>(3)</em> Retention of records. </p><p class="depth0"><em>(i)</em> Record retention requirements set  forth in this section do not supersede the record retention requirements  of any other regulations in this subchapter.</p><p class="depth0"><em>(ii)</em> Except as provided in paragraph (h)(3)(iii) of this section,  documentation records, raw data, and specimens pertaining to a study and  required to be retained by this part shall be archived for a period of  at least ten years following the completion of the study.</p><p class="depth0"><em>(iii)</em> Wet specimens, samples of test fuel, additive/base fuel  mixtures, or reference substances, and specially prepared material which  are relatively fragile and differ markedly in stability and quality  during storage, shall be retained only as long as the quality of the  preparation affords evaluation. Specimens obtained from mutagenicity  tests, wet specimens of blood, urine, feces, biological fluids, do not  need to be retained after quality assurance verification. In no case  shall retention be required for a longer period than that set forth in  paragraph (h)(3)(ii) of this section.</p><p class="depth0"><em>(iv)</em> The master schedule sheet, copies of protocols, and records of  quality assurance inspections, as required by Sec. 79.60(b)(4)(iii)  shall be maintained by   the quality assurance unit as an easily accessible system of records for  the period of time specified in paragraph (h)(3)(ii) of this section.</p><p class="depth0"><em>(v)</em> Summaries of training and experience and job descriptions  required to be maintained by Sec. 79.60(b)(1)(ii) may be retained along  with all other testing facility employment records for the length of  time specified in paragraph (h)(3)(ii) of this section.</p><p class="depth0"><em>(vi)</em> Records and reports of the maintenance and calibration and  inspection of equipment, as required by Sec. 79.60(d)(2) (ii) and (iii),  shall be retained for the length of time specified in paragraph  (h)(3)(ii) of this section.</p><p class="depth0"><em>(vii)</em> If a facility conducting testing or an archive contracting  facility goes out of business, all raw data, documentation, and other  material specified in this section shall be transferred to the sponsor  of the study for archival.</p><p class="depth0"><em>(viii)</em> Records required by this section may be retained either as  original records or as true copies such as photocopies, microfilm,  microfiche, or other accurate reproductions of the original records.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
